Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol A Kruse

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Neuroimmunology|July 22, 2004
Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cellsNisha V Kulprathipanja, Carol A Kruse
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-betaGerman G Gomez, Carol A Kruse
Methods in Molecular Medicine|November 25, 2003
Isolation and culture of human brain tumor cellsGerman G Gomez, Carol A Kruse
Gene Therapy & Molecular Biology|July 1, 2006
Mechanisms of malignant glioma immune resistance and sources of immunosuppressionGerman G Gomez, Carol A Kruse
Cancer Genetics and Cytogenetics|March 11, 2006
Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterizationGerman G Gomez, Marileila Varella-Garcia, Carol A Kruse
Gene Therapy & Molecular Biology|December 11, 2008
Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factorsGerman G Gomez, Michelle J Hickey, Richard Tritz, et al.
Oncoimmunology|November 19, 2013
Combining cellular and gene therapy approaches for treatment of intracranial tumorsMichelle J Hickey, Noriyuki Kasahara, Barbara M Mueller, et al.
Gene Therapy & Molecular Biology|February 10, 2006
Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review ArticleRichard Tritz, Cellia Habita, Joan M Robbins, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 13, 2003
Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytesPatric M Schiltz, German G Gomez, Susana B Read, et al.
Neuro-Oncology|May 12, 2004
Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumorsGerman G Gomez, Susana B Read, Lazaro E Gerschenson, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|July 22, 2004
Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cellsNisha V Kulprathipanja, Carol A Kruse
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-betaGerman G Gomez, Carol A Kruse
Methods in Molecular Medicine|November 25, 2003
Isolation and culture of human brain tumor cellsGerman G Gomez, Carol A Kruse
Gene Therapy & Molecular Biology|July 1, 2006
Mechanisms of malignant glioma immune resistance and sources of immunosuppressionGerman G Gomez, Carol A Kruse
Cancer Genetics and Cytogenetics|March 11, 2006
Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterizationGerman G Gomez, Marileila Varella-Garcia, Carol A Kruse
Gene Therapy & Molecular Biology|December 11, 2008
Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factorsGerman G Gomez, Michelle J Hickey, Richard Tritz, et al.
Oncoimmunology|November 19, 2013
Combining cellular and gene therapy approaches for treatment of intracranial tumorsMichelle J Hickey, Noriyuki Kasahara, Barbara M Mueller, et al.
Gene Therapy & Molecular Biology|February 10, 2006
Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review ArticleRichard Tritz, Cellia Habita, Joan M Robbins, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 13, 2003
Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytesPatric M Schiltz, German G Gomez, Susana B Read, et al.
Neuro-Oncology|May 12, 2004
Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumorsGerman G Gomez, Susana B Read, Lazaro E Gerschenson, et al.
Pageof 4